SCHEMBL7727751

SCHEMBL7727751

NCC(=O)N[C@@H]1CN[C@@H](C(=O)N[C@H](CCc2ccccc2)C(=O)NCCCc2ccccc2)C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.45
CHRNB4 P30926 1/20 0.45
CHRNA3 P32297 1/20 0.45
CHRNA4 P43681 1/20 0.45
HDAC3 O15379 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
NCOR2 Q9Y618 1/20 0.45
CALCRL Q16602 1/20 0.42
PADI4 Q9UM07 1/20 0.42
PADI2 Q9Y2J8 1/20 0.42
MMP8 P22894 3/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
KMT2A Q03164 2/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8143408 0.88 CTSC (0.41) F2
SCHEMBL7722172 0.82 MMP2 (0.40) HDAC3HDAC1HDAC2HDAC10HDAC11
Hydrochloric Acid SCHEMBL7729651 0.82 MMP2 (0.40) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL17770546 0.81 POLB (0.41) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL7722316 0.81 F2 (0.36) CHRNB2CHRNB4CHRNA3CHRNA4HDAC3
SCHEMBL21436517 0.81 F2 (0.36) CHRNB2CHRNB4CHRNA3CHRNA4HDAC3
Hydrochloric Acid SCHEMBL7729657 0.81 POLB (0.40) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL21436233 0.80 MMP8 (0.37) PADI4PADI2MMP8F2
SCHEMBL7723535 0.80 ALOX15 (0.44) HDAC1PADI4PADI2KMT2AMEN1
SCHEMBL21523180 0.80 ALOX15 (0.44) HDAC1PADI4PADI2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed